These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 27677286)

  • 1. Silencing Livin induces apoptotic and autophagic cell death, increasing chemotherapeutic sensitivity to cisplatin of renal carcinoma cells.
    Wang Z; Liu S; Ding K; Ding S; Li C; Lu J; Gao D; Zhang T; Bi D
    Tumour Biol; 2016 Nov; 37(11):15133-15143. PubMed ID: 27677286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene.
    Wang TS; Ding QQ; Guo RH; Shen H; Sun J; Lu KH; You SH; Ge HM; Shu YQ; Liu P
    Biomed Pharmacother; 2010 May; 64(5):333-8. PubMed ID: 19914791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of the antiapoptotic factor Livin contributes to cisplatin resistance in colon cancer cells.
    Ding ZY; Liu GH; Olsson B; Sun XF
    Tumour Biol; 2013 Apr; 34(2):683-93. PubMed ID: 23188704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of livin in gastric cancer and effect of silencing of the livin gene on apoptosis in gastric cancer cells].
    Liu P; Wang TS; You SH; Ge HM
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):570-4. PubMed ID: 18210873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Co-transfection with Livin and survivin shRNA expression vectors on biological behavior of HepG2 cells.
    Xu W; Chang H; Qin CK; Zhai YP
    Asian Pac J Cancer Prev; 2013; 14(9):5467-72. PubMed ID: 24175843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisense oligonucleotide targeting Livin induces apoptosis of human bladder cancer cell via a mechanism involving caspase 3.
    Liu C; Wu X; Luo C; Hu Z; Yin Z; He Y; Du H; Zhang W; Jiang Q; Lin Y
    J Exp Clin Cancer Res; 2010 Jun; 29(1):63. PubMed ID: 20525250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. siRNA directed against Livin inhibits tumor growth and induces apoptosis in human glioma cells.
    Yuan B; Ran B; Wang S; Liu Z; Zheng Z; Chen H
    J Neurooncol; 2012 Mar; 107(1):81-7. PubMed ID: 22086237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells.
    Wong JC; Bathina M; Fiscus RR
    J Cell Biochem; 2012 Nov; 113(11):3587-98. PubMed ID: 22740515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. siRNA targeting Livin decreases tumor in a xenograft model for colon cancer.
    Oh BY; Lee RA; Kim KH
    World J Gastroenterol; 2011 May; 17(20):2563-71. PubMed ID: 21633662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted inhibition of Livin resensitizes renal cancer cells towards apoptosis.
    Crnković-Mertens I; Wagener N; Semzow J; Gröne EF; Haferkamp A; Hohenfellner M; Butz K; Hoppe-Seyler F
    Cell Mol Life Sci; 2007 May; 64(9):1137-44. PubMed ID: 17437058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and role of the inhibitor of apoptosis protein livin in chemotherapy sensitivity of ovarian carcinoma.
    Liu X; Wang A; Gao H; Yuan Z; Jiao Y
    Int J Oncol; 2012 Sep; 41(3):1021-8. PubMed ID: 22766624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the apoptosis inhibitor livin in renal cell carcinomas: correlations with pathology and outcome.
    Kempkensteffen C; Hinz S; Christoph F; Krause H; Koellermann J; Magheli A; Schrader M; Schostak M; Miller K; Weikert S
    Tumour Biol; 2007; 28(3):132-8. PubMed ID: 17519534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of inhibitor of apoptosis protein Livin in renal cell carcinoma and non-tumorous adult kidney.
    Wagener N; Crnković-Mertens I; Vetter C; Macher-Göppinger S; Bedke J; Gröne EF; Zentgraf H; Pritsch M; Hoppe-Seyler K; Buse S; Haferkamp A; Autschbach F; Hohenfellner M; Hoppe-Seyler F
    Br J Cancer; 2007 Nov; 97(9):1271-6. PubMed ID: 17968430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Livin gene RNA interference on apoptosis of cervical cancer HeLa cells and enhanced sensitivity to cisplatin.
    Yu L; Wang Z
    J Huazhong Univ Sci Technolog Med Sci; 2009 Oct; 29(5):625-30. PubMed ID: 19821098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.
    Li F; Yin X; Luo X; Li HY; Su X; Wang XY; Chen L; Zheng K; Ren GS
    Cell Signal; 2013 Jun; 25(6):1413-22. PubMed ID: 23524337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment.
    Liu HB; Kong CZ; Zeng Y; Liu XK; Bi JB; Jiang YJ; Han S
    Urol Oncol; 2009; 27(3):277-83. PubMed ID: 18555709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing Livin gene expression to inhibit proliferation and enhance chemosensitivity in tumor cells.
    Wang R; Lin F; Wang X; Gao P; Dong K; Zou AM; Cheng SY; Wei SH; Zhang HZ
    Cancer Gene Ther; 2008 Jun; 15(6):402-12. PubMed ID: 18340356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [RNAi-mediated gene silencing of livin synergistic with epirubicin enhance apoptosis of human breast cancer cells].
    Liang CY; Ma P; Liu XL
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1703-6. PubMed ID: 19024543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Livin contributes to tumor hypoxia-induced resistance to cytotoxic therapies in glioblastoma multiforme.
    Hsieh CH; Lin YJ; Wu CP; Lee HT; Shyu WC; Wang CC
    Clin Cancer Res; 2015 Jan; 21(2):460-70. PubMed ID: 25370472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Livin and the inhibition of tumor progression by Livin silencing in laryngohypopharyngeal cancer.
    Yoon TM; Kim SA; Lee DH; Lee JK; Park YL; Lee KH; Chung IJ; Joo YE; Lim SC
    In Vivo; 2014; 28(5):751-9. PubMed ID: 25189886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.